Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

EMA backs 15 new medicines for use in EU

EMA backs 15 new medicines for use in EU AstraZeneca and Almirall. There was good news for AstraZeneca (AZ), which received positive opinions for two of its medicines. ... Aclidinium / formoterol fumarate, which is set to be marketed as Brimica Genuair or Duaklir Genuair depending on the country

The M&A trend in pharma

The M&A trend in pharma It is also driving acquisitions that complement the buyer's existing core products, as evidenced by AstraZeneca's $1.2bn acquisition of Almirall's respiratory division and the deal between GSK

Novartis' Ultibro tops Seretide in comparative COPD trial

Novartis' Ultibro tops Seretide in comparative COPD trial With Seretide already succumbing to generic competition and other entrants from AstraZeneca and Forest Laboratories/Almirall also coming through the pipeline, the market is expected to fragment with the new generation

Deal Watch table for July 2014

Deal Watch table for July 2014 2, 700. Almirall/ AstraZeneca. Asset acquisition. Respiratory business including various respiratory assets and device capabilities.

Pharma deals during July 2014

Pharma deals during July 2014 AZ will also acquire Almirall Sofotec, Almirall's inhalation device business which includes Genuair, its novel multi-dose dry powder inhalation (DPI) device. ... Almirall will receive $875m upfront and up to $1.22bn in development, launch, and

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...